Skip to main content

Table 3 Top 20 potential SUMO-1 targeting TFs after KSHV reactivation

From: The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation

Rank Name Transfac TFBS # (in TSS±500 bp) Peak # of TFBS (in TSS±500 bp) % of TFBS Peak (in TSS±500 bp) Gene #
0 h 12 h 0 h 12 h 0 h 12 h
1 ETS1 V$CETS1P54_01 1587 341 262 21.5% 16.5% 294 229
2 STAT4 V$STAT4_01 106 17 17 16.0% 16.0% 4 4
3 ELK1 V$ELK1_02 1667 333 254 20.0% 15.2% 279 215
4 GABPA/NRF-2 V$NRF2_01 1577 336 237 21.3% 15.0% 286 206
5 STAT1 V$STAT1_03 282 50 41 17.7% 14.5% 48 39
6 NFATC1/2/3/4 V$NFAT_Q6 487 48 70 9.9% 14.4% 22 23
7 STAT5A V$STAT5A_02 982 118 129 12.0% 13.1% 95 104
8 MYC/MAX V$MYCMAX_02 580 90 76 15.5% 13.1% 68 55
9 CREB1 V$CREB_01 666 103 87 15.5% 13.1% 97 83
10 CUTL1 V$CDPCR1_01 582 59 73 10.1% 12.5% 54 49
  1. bold: transcription factor with evidence of SUMO modification.